France: Novo Nordisk and Eli Lilly fined for illegal advertising

The French National Medicine Safety Agency has fined pharmaceutical companies Novo Nordisk and Eli Lilly for advertising campaigns deemed non-compliant with French regulations.

Published 10sem2 sources✓ Confirmedupdated 10sem

Lire en français

≈ 22sSpeed

The fact

These penalties aim to strengthen control of commercial communications to patients.

Both pharmaceutical giants must adjust their promotional strategies in France.

2 sources — click a link to read an article on the topic:

Sciences et Avenir

RFI

Explore this topic

France Novo Nordisk Eli Lilly Agence nationale de sécurité du médicament #France #pharmaceutique #publicité

What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.

Follow topic →

Auto-synthesis from 2 media sources · identified on May 4, 2026

← Back to home

The fact

Read more

French medicines agency sanctions Novo Nordisk and Eli Lilly for obesity drug advertising

Anti-obesity drugs: Novo Nordisk and Eli Lilly ads penalized

Anti-obesity drugs: Novo Nordisk and Eli Lilly sanctioned for deceptive practices

Novo Nordisk and Eli Lilly sanctioned for obesity drug misuse

EU investigates Sanofi for alleged anti-competitive practices

Eli Lilly cuts back on pharmaceutical plant investments